Cargando…
Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage
OBJECTIVE: Hematoma enlargement (HE) is associated with clinical outcomes after supratentorial intracerebral hemorrhage (ICH). This study evaluates whether HE characteristics and association with functional outcome differ in deep versus lobar ICH. METHODS: Pooled analysis of individual patient data...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086015/ https://www.ncbi.nlm.nih.gov/pubmed/32133793 http://dx.doi.org/10.1002/acn3.51001 |
_version_ | 1783509050172899328 |
---|---|
author | Sembill, Jochen A. Kuramatsu, Joji B. Gerner, Stefan T. Sprügel, Maximilian I. Roeder, Sebastian S. Madžar, Dominik Hagen, Manuel Hoelter, Philip Lücking, Hannes Dörfler, Arnd Schwab, Stefan Huttner, Hagen B. |
author_facet | Sembill, Jochen A. Kuramatsu, Joji B. Gerner, Stefan T. Sprügel, Maximilian I. Roeder, Sebastian S. Madžar, Dominik Hagen, Manuel Hoelter, Philip Lücking, Hannes Dörfler, Arnd Schwab, Stefan Huttner, Hagen B. |
author_sort | Sembill, Jochen A. |
collection | PubMed |
description | OBJECTIVE: Hematoma enlargement (HE) is associated with clinical outcomes after supratentorial intracerebral hemorrhage (ICH). This study evaluates whether HE characteristics and association with functional outcome differ in deep versus lobar ICH. METHODS: Pooled analysis of individual patient data between January 2006 and December 2015 from a German‐wide cohort study (RETRACE, I + II) investigating ICH related to oral anticoagulants (OAC) at 22 participating centers, and from one single‐center registry (UKER‐ICH) investigating non‐OAC‐ICH patients. Altogether, 1954 supratentorial ICH patients were eligible for outcome analyses, which were separately conducted or controlled for OAC, that is, vitamin‐K‐antagonists (VKA, n = 1186) and non‐vitamin‐K‐antagonist‐oral‐anticoagulants (NOAC, n = 107). Confounding was addressed using propensity score matching, cox regression modeling and multivariate modeling. Main outcomes were occurrence, extent, and timing of HE (>33%/>6 mL) and its association with 3‐month functional outcome. RESULTS: Occurrence of HE was not different after deep versus lobar ICH in patients with non‐OAC‐ICH (39/356 [11.0%] vs. 36/305 [11.8%], P = 0.73), VKA‐ICH (249/681 [36.6%] vs. 183/505 [36.2%], P = 0.91), and NOAC‐ICH (21/69 [30.4%] vs. 12/38 [31.6%], P = 0.90). HE extent did not differ after non‐OAC‐ICH (deep:+59% [40–122] vs. lobar:+74% [37–124], P = 0.65), but both patients with VKA‐ICH and NOAC‐ICH showed greater HE extent after deep ICH [VKA‐ICH, deep: +94% [54–199] vs. lobar: +56% [35–116], P < 0.001; NOAC‐ICH, deep: +74% [56–123] vs. lobar: +40% [21–49], P = 0.001). Deep compared to lobar ICH patients had higher HE hazard during first 13.5 h after onset (Hazard ratio [HR]: 1.85 [1.03–3.31], P = 0.04), followed by lower hazard (13.5–26.5 h, HR: 0.46 [0.23–0.89], P = 0.02), and equal hazard thereafter (HR: 0.96 [0.56–1.65], P = 0.89). Odds ratio for unfavorable outcome was higher after HE in deep (4.31 [2.71–6.86], P < 0.001) versus lobar ICH (2.82 [1.71–4.66], P < 0.001), and only significant after small‐medium (1st volume‐quarter, deep: 3.09 [1.52–6.29], P < 0.01; lobar: 3.86 [1.35–11.04], P = 0.01) as opposed to large‐sized ICH (4th volume‐quarter, deep: 1.09 [0.13–9.20], P = 0.94; lobar: 2.24 [0.72–7.04], P = 0.17). INTERPRETATION: HE occurrence does not differ among deep and lobar ICH. However, compared to lobar ICH, HE after deep ICH is of greater extent in OAC‐ICH, occurs earlier and may be of greater clinical relevance. Overall, clinical significance is more apparent after small–medium compared to large‐sized bleedings. |
format | Online Article Text |
id | pubmed-7086015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70860152020-03-24 Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage Sembill, Jochen A. Kuramatsu, Joji B. Gerner, Stefan T. Sprügel, Maximilian I. Roeder, Sebastian S. Madžar, Dominik Hagen, Manuel Hoelter, Philip Lücking, Hannes Dörfler, Arnd Schwab, Stefan Huttner, Hagen B. Ann Clin Transl Neurol Research Articles OBJECTIVE: Hematoma enlargement (HE) is associated with clinical outcomes after supratentorial intracerebral hemorrhage (ICH). This study evaluates whether HE characteristics and association with functional outcome differ in deep versus lobar ICH. METHODS: Pooled analysis of individual patient data between January 2006 and December 2015 from a German‐wide cohort study (RETRACE, I + II) investigating ICH related to oral anticoagulants (OAC) at 22 participating centers, and from one single‐center registry (UKER‐ICH) investigating non‐OAC‐ICH patients. Altogether, 1954 supratentorial ICH patients were eligible for outcome analyses, which were separately conducted or controlled for OAC, that is, vitamin‐K‐antagonists (VKA, n = 1186) and non‐vitamin‐K‐antagonist‐oral‐anticoagulants (NOAC, n = 107). Confounding was addressed using propensity score matching, cox regression modeling and multivariate modeling. Main outcomes were occurrence, extent, and timing of HE (>33%/>6 mL) and its association with 3‐month functional outcome. RESULTS: Occurrence of HE was not different after deep versus lobar ICH in patients with non‐OAC‐ICH (39/356 [11.0%] vs. 36/305 [11.8%], P = 0.73), VKA‐ICH (249/681 [36.6%] vs. 183/505 [36.2%], P = 0.91), and NOAC‐ICH (21/69 [30.4%] vs. 12/38 [31.6%], P = 0.90). HE extent did not differ after non‐OAC‐ICH (deep:+59% [40–122] vs. lobar:+74% [37–124], P = 0.65), but both patients with VKA‐ICH and NOAC‐ICH showed greater HE extent after deep ICH [VKA‐ICH, deep: +94% [54–199] vs. lobar: +56% [35–116], P < 0.001; NOAC‐ICH, deep: +74% [56–123] vs. lobar: +40% [21–49], P = 0.001). Deep compared to lobar ICH patients had higher HE hazard during first 13.5 h after onset (Hazard ratio [HR]: 1.85 [1.03–3.31], P = 0.04), followed by lower hazard (13.5–26.5 h, HR: 0.46 [0.23–0.89], P = 0.02), and equal hazard thereafter (HR: 0.96 [0.56–1.65], P = 0.89). Odds ratio for unfavorable outcome was higher after HE in deep (4.31 [2.71–6.86], P < 0.001) versus lobar ICH (2.82 [1.71–4.66], P < 0.001), and only significant after small‐medium (1st volume‐quarter, deep: 3.09 [1.52–6.29], P < 0.01; lobar: 3.86 [1.35–11.04], P = 0.01) as opposed to large‐sized ICH (4th volume‐quarter, deep: 1.09 [0.13–9.20], P = 0.94; lobar: 2.24 [0.72–7.04], P = 0.17). INTERPRETATION: HE occurrence does not differ among deep and lobar ICH. However, compared to lobar ICH, HE after deep ICH is of greater extent in OAC‐ICH, occurs earlier and may be of greater clinical relevance. Overall, clinical significance is more apparent after small–medium compared to large‐sized bleedings. John Wiley and Sons Inc. 2020-03-04 /pmc/articles/PMC7086015/ /pubmed/32133793 http://dx.doi.org/10.1002/acn3.51001 Text en © 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Sembill, Jochen A. Kuramatsu, Joji B. Gerner, Stefan T. Sprügel, Maximilian I. Roeder, Sebastian S. Madžar, Dominik Hagen, Manuel Hoelter, Philip Lücking, Hannes Dörfler, Arnd Schwab, Stefan Huttner, Hagen B. Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage |
title | Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage |
title_full | Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage |
title_fullStr | Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage |
title_full_unstemmed | Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage |
title_short | Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage |
title_sort | hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086015/ https://www.ncbi.nlm.nih.gov/pubmed/32133793 http://dx.doi.org/10.1002/acn3.51001 |
work_keys_str_mv | AT sembilljochena hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT kuramatsujojib hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT gernerstefant hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT sprugelmaximiliani hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT roedersebastians hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT madzardominik hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT hagenmanuel hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT hoelterphilip hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT luckinghannes hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT dorflerarnd hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT schwabstefan hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage AT huttnerhagenb hematomaenlargementcharacteristicsindeepversuslobarintracerebralhemorrhage |